Jens Siveke
Tumor and host heterogeneity in PDAC
Marija Trajkovic-Arsic
Theranostics in PDAC and beyond
Department of Translational Oncology DKFZ and Bridge Institute of Experimental Cancer Therapy, University Hospital Essen
Jens Siveke is the chair of the Department of Translational Oncology DKFZ and Bridge Institute of Experimental Cancer Therapy at University Hospital Essen. Jens is the speaker of the BMBF-funded Saturn3 consortium, which focuses on 3 hard to treat tumor entities – pancreatic, breast and colon cancer. His lab is focused on unraveling tumor-host interactions in pancreatic cancer with the aim of developing personalized therapeutic interventions.
Marija Trajkovic-Arsic research focuses on developing theranostic approaches combining imaging based methods and radionuclides for pancreatic cancer and other tumor entities.
Host: Dieter Saur
Division of Translational Cancer Research, German Cancer Research Center, Heidelberg; Institute of Experimental Cancer Therapy, DKTK partner site Munich and TranslaTUM – Central Institute for Translational Cancer Research, School of Medicine and Health, Technical University of Munich
